MedTrace Logo

A Combined Supplementation of Rosemary and Daylily for Enhancing Sleep Quality in Middle-Aged Adults

NCT06859879 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-01-02

No results posted yet for this study

Summary

This study aims to investigate the impact of supplementation with two different doses of Rosemary and Daylily herbal extract on various health outcomes in middle-aged adults. Over an eight-week period, the trial will assess improvements in sleep quality, circadian rhythms, energy metabolism, and relevant biochemical markers. The study employs a randomized, placebo-controlled, crossover design to evaluate the efficacy of these supplements in enhancing overall health and well-being.

Conditions

  • Sleep

Interventions

DIETARY_SUPPLEMENT

Dietary Supplement: low-dose Rosemary and Daylily extract

Supplement containing Rosemary and Daylily extract

DIETARY_SUPPLEMENT

Dietary Supplement: medium-dose Rosemary and Daylily extract

Supplement containing Rosemary and Daylily extract

DIETARY_SUPPLEMENT

Dietary Supplement: control

Supplement containing placebo

Sponsors & Collaborators

  • University of Novi Sad, Faculty of Sport and Physical Education

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2025-11-30
Completion
2025-12-15

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06859879 on ClinicalTrials.gov